NL-OMON46797
Completed
Not Applicable
Cerebral amyloid angiopathy fluid biomarkers evaluation (CAFE) - CAFE
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Radboud Universitair Medisch Centrum
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusion criteria for ICH due to cerebral hypertensive vasculopathy patients:;In order to be eligible to participate, a subject must meet the following criteria:
- •\- Intracerebral hemorrhage in the basal ganglia or thalamus in patients with hypertension (defined as known history of hypertension, or on antihypertensive drugs either before or in the chronic phase after ICH). Note: patients with high blood pressure during the period of admission after ICH only without any of the above mentioned criteria will not be included.
- •\- Subjects are mentally competent to take a decision on participation.
- •\- Written informed consent
- •\- Age \>55 years;Inclusion criteria for Healthy volunteers
- •\- Age \>55 years
- •\- Subject is in good health as established by medical history, physical examination
- •\- MMSE 28 or higher
Exclusion Criteria
- •\- Evidence of recent neurological diseases other than hypertensive cerebral vasculopathy e.g. brain tumors, other vascular conditions (e.g. malformations), inflammatory or infectious disease)
- •\- Evidence of recent (\< 3 months prior to planned lumbar puncture) ischemic or hemorrhagic stroke
- •\- Presence of blood coagulopathy, established by medical history
- •\- History of neurological or psychiatric disease
- •\- Allergy to local anesthetic agents
- •\- Contra\-indication for lumbar puncture: medical history of compression of spinal cord, spinal surgery, skin infection, developmental abnormalities in lower spine
- •\- Subjects who are currently participating in another study or have participated in a clinical study within the previous 30 days, based on their own report
- •\- Subjects with a history of drug or alcohol abuse
- •\- Subjects who are part of the study staff personnel or family members of the study staff personnel;Contraindications for MRI:
- •\- Intracranial clips
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Cerebral amyloid angiopathy fluid biomarkers evaluation - Alzheimer*s Disease (CAFÉ-AD)ziekte van AlzheimerCerebral amyloid angiopathysmall vessel disease10007963NL-OMON48320Radboud Universitair Medisch Centrum50
Recruiting
Not Applicable
SEarchiNg BiomarkErs Cerebral Amyloid Angiopathy (SENECA)Cerebral Amyloid AngiopathyNCT04204642Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta500
Recruiting
Phase 2
Plasma biomarker reflecting cerebral amyloid deposition: a multicenter study for the clinical applicatioAlzheimer's disease Other Dementia Mild cognitive impairment (MCI) Healthy volunteerJPRN-UMIN000023976ational Center for Geriatrics and Gerontology400
Completed
Not Applicable
Cerebral Amyloid Angiopathy: Vascular Imaging and fluid markers of Amyloid depositioneurodegenerative aandoeningen (vasculair)Cerebral amyloid angiopathysmall vessel disease10007963NL-OMON42188niversitair Medisch Centrum Sint Radboud100
Recruiting
Not Applicable
Cerebral amyloid angiopathy and clinical phenotype of Alzheimer's disease: a prospective multimodality imaging studyF00I68.0Dementia in Alzheimer diseaseCerebral amyloid angiopathyDRKS00030633Klinik für Neurologie Uniklinik RWTH Aachen40